Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade

NCT02454868 is registered in ClinicalTrials.gov with Brasilia University Hospital as lead sponsor.

NCT NCT02454868
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02454868 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Remifentanil Minimum Effective Dose for Children Intubation Without Neuromuscular Blockade
Lead sponsor
Brasilia University Hospital
Phase
Phase 4
Overall status
Completed
Start date
July 31, 2016
Completion date
July 31, 2016
Enrollment
30 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

underdosing of unspecified general anesthetics